UCART22

DB17466Investigational

UCART22 are allogeneic CD22-specific universal CAR-expressing T lymphocytes.

Mechanism
Curator reviewed
Also known as
Allogeneic gene-edited CAR T cells UCART22 · Allogeneic TALEN gene-edited CAR T-Cells UCART22 · Allogenic engineered T cells expressing anti-CD22 CAR UCART22
Code names
UCART-22

Resolves to

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with UCART22, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account